Speaker
Executive Director, Orum Therapeutics, Inc.
Maysoun Shomali, Executive Director at Orum Therapeutics, Inc., is speaking at 9th TPD & Induced Proximity Summit (Boston, United States of America, 26–29 Oct 2026) in the session “Next-Generation Degrader Antibody Conjugates”.
26–29 Oct 2026Boston, United States of America
Professor, Harvard Medical School
President & Chief Executive Officer, Arvinas, Inc.
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Associate Director, Medicinal Chemistry, AstraZeneca
Science Partner, Flagship Pioneering
Chief Business Officer, Nurix Therapeutics, Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Maysoun Shomali, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].